Consider increased clinical or laboratory monitoring for medications that have a narrow therapeutic index or that require clinical monitoring Use in Specific Populations Pregnancy: Available data with semaglutide use in pregnant women are not sufficient to determine a drug associated risk for major birth defects, miscarriage, or other adverse maternal or fetal outcomes
During the first few months of the treatment when dosing titration occurs, it is essential to maintain close monitoring for side effects
Nevertheless, if side effects persist or deteriorate, seek guidance from a healthcare professional
Prescribing Information: Ozempic, (semaglutide) injection, for subcutaneous use
In the study, participants who took GLP-1 medications such as semaglutide, tirzepatide, or liraglutide showed a slower increase in breath alcohol concentration, even though they consumed the same amount of alcohol as others